Paper Details
- Home
- Paper Details
Antiestrogenic properties of raloxifene.
Author: DraperM W, FlowersD E, HusterW J, NeildJ A, ZerbeR L
Original Abstract of the Article :
This 21-day, open-label study evaluated the effects of raloxifene and tamoxifen on estrogen-induced changes in serum levels of anterior pituitary hormones (prolactin, luteinizing hormone, and follicle-stimulating hormone), sex steroids (testosterone, estradiol), and binding globulins [thyroid bindin...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1159/000139284
データ提供:米国国立医学図書館(NLM)
Raloxifene's Antiestrogenic Properties: A Sandcastle in the Desert of Estrogen
Estrogen, a hormone that plays a vital role in the human body, is like a desert oasis - essential but can be disruptive when out of balance. This study focused on raloxifene, a drug that acts like a sandcastle on the beach of estrogen, blocking its effects. The researchers investigated how raloxifene and tamoxifen, another estrogen-blocking drug, affected estrogen-induced changes in the body, including hormone levels and protein binding. They conducted a 21-day study on 17 healthy men who were randomly assigned to receive raloxifene, tamoxifen, or a placebo. The results were as intricate as the patterns left by the wind on the sand: while both drugs were effective in blocking estrogen's effects, tamoxifen had a more potent and widespread effect. Raloxifene, however, showed a significant antiestrogenic effect on T3 resin uptake, a marker of thyroid hormone activity, making it a potential therapeutic option for conditions where estrogen activity needs to be modulated.Raloxifene: A Sandcastle with Potential
This study demonstrated that raloxifene, a drug originally developed for postmenopausal osteoporosis, possesses antiestrogenic properties in humans. Its potential to act as a selective estrogen receptor modulator (SERM) - a sandcastle that selectively blocks or enhances estrogen's effects in different tissues - makes it a promising drug for various conditions. The study's findings are as clear as a desert sky at night, providing valuable insights for future research on raloxifene.Estrogen and Raloxifene: Balancing the Desert Oasis
Estrogen plays a crucial role in the human body, but too much or too little can lead to various health issues. Raloxifene, with its selective antiestrogenic properties, could be a helpful tool for managing conditions where estrogen levels need to be adjusted. It's important to remember that raloxifene is a prescription medication, and its use should be discussed with a healthcare professional.Dr. Camel's Conclusion
Raloxifene, a selective estrogen receptor modulator, has shown potential as an antiestrogenic agent in humans. This research, as clear as a desert sky after a rare downpour, is crucial in understanding how to manage estrogen levels and potential health issues associated with estrogen imbalance.Date :
- Date Completed 1995-07-21
- Date Revised 2018-02-14
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.